Quest Diagnostics
DGX
Verlauf der Aktienposition
Weitere Fonds mit DGX im Portfolio
Vanguard Group
Malvern, Pennsylvania
6,9 Bio. $ AUM
27,45 %
1-J.-Rendite (gesch.)
Macquarie Group
Sydney, NSW 2000, Australia
23,8 Mrd. $ AUM
34,14 %
1-J.-Rendite (gesch.)
T. Rowe Price Associates
Baltimore, Maryland
994 Mrd. $ AUM
38,51 %
1-J.-Rendite (gesch.)
State Street
Boston, Massachusetts
3,44 Bio. $ AUM
36,12 %
1-J.-Rendite (gesch.)
Capital International Investors
Los Angeles, California
483 Mrd. $ AUM
27,72 %
1-J.-Rendite (gesch.)
American Century Companies
Kansas City, Missouri
229 Mrd. $ AUM
33,35 %
1-J.-Rendite (gesch.)
Davis Selected Advisers
Tucson, Arizona
23,2 Mrd. $ AUM
18,42 %
1-J.-Rendite (gesch.)
BlackRock Institutional Trust
San Francisco, California
675 Mrd. $ AUM
16,07 %
1-J.-Rendite (gesch.)
BlackRock Advisors
Wilmington, Delaware
98,8 Mrd. $ AUM
15,8 %
1-J.-Rendite (gesch.)
Boston Partners
Boston, Massachusetts
111 Mrd. $ AUM
30,48 %
1-J.-Rendite (gesch.)